Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 234,738 | 264,560 | 194,701 | 250,867 | 274,272 |
| Receivables | 22,918 | 26,184 | 31,762 | 20,316 | 24,030 |
| Inventories | 18,042 | 17,763 | 17,447 | 18,387 | 16,072 |
| Other current assets | 5,523 | 5,664 | 7,180 | 9,450 | 18,631 |
| TOTAL | $287,149 | $318,755 | $257,989 | $307,390 | $333,005 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | 5,156 | 5,075 | 5,721 |
| Other Non-Current Assets | 2,609 | 2,805 | 9,394 | 9,515 | 10,353 |
| TOTAL | $2,609 | $2,806 | $14,550 | $14,590 | $16,074 |
| Total Assets | $289,758 | $321,561 | $272,539 | $321,980 | $349,079 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,119 | 9,616 | 15,592 | 18,029 | 14,372 |
| Accrued Expenses | 53,925 | 54,984 | 42,202 | 62,440 | 53,307 |
| TOTAL | $62,044 | $64,600 | $57,794 | $80,469 | $67,679 |
| Non-Current Liabilities | |||||
| Long Term Debt | 115,206 | 114,473 | 113,823 | 113,632 | 114,189 |
| Other Non-Current Liabilities | 350,691 | 341,672 | 339,145 | 330,521 | 339,157 |
| TOTAL | $465,897 | $456,145 | $452,968 | $444,153 | $453,346 |
| Total Liabilities | $527,941 | $520,745 | $510,762 | $524,622 | $521,025 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,877 | 112,499 | 99,178 | 99,084 | 96,690 |
| Common Shares | 9,763 | 9,753 | 8,439 | 8,425 | 8,233 |
| Retained earnings | -1,629,532 | -1,588,566 | -1,531,920 | -1,493,318 | -1,462,591 |
| Other shareholders' equity | -907 | -595 | -1,299 | -1,641 | -19 |
| TOTAL | $-238,183 | $-199,184 | $-238,223 | $-202,642 | $-171,946 |
| Total Liabilities And Equity | $289,758 | $321,561 | $272,539 | $321,980 | $349,079 |